Authors: Godwin, A Hartenstein, M Muller, AHE Brocchini, S

Citation: A. Godwin et al., Narrow molecular weight distribution precursors for polymer-drug conjugates, ANGEW CHEM, 40(3), 2001, pp. 594-597

Authors: Godwin, A Bolina, K Clochard, M Dinand, E Rankin, S Simic, S Brocchini, S

Citation: A. Godwin et al., New strategies for polymer development in pharmaceutical science - a shortreview, J PHARM PHA, 53(9), 2001, pp. 1175-1184

Authors: Davis, A Godwin, A Lippman, J Olson, W Kafrissen, M

Citation: A. Davis et al., Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding, OBSTET GYN, 96(6), 2000, pp. 913-920

Authors: Sulak, P Lippman, J Siu, C Massaro, J Godwin, A

Citation: P. Sulak et al., Clinical comparison of triphasic norgestimate/35 mu g ethinyl estradiol and monophasic norethindrone acetate/20 mu g ethinyl estradiol - Cycle control, lipid effects, and user satisfaction, CONTRACEPT, 59(3), 1999, pp. 161-166

Authors: Wang-Gohrke, S Weikel, W Risch, H Vesprini, D Abrahamson, J Lerman, C Godwin, A Moslehi, R Olipade, O Brunet, JS Stickeler, E Kieback, DG Kreienberg, R Weber, B Narod, SA Runnebaum, IB

Citation: S. Wang-gohrke et al., Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations, BR J CANC, 81(1), 1999, pp. 179-183